Pharma-Bio Serv (PBSV) Enterprise Value (2010 - 2026)

Pharma-Bio Serv's Enterprise Value history runs 17 years deep, the most recent figure standing at -$8.5 million for Q2 2026.

• Enterprise Value for Q2 2026 came in at -$8.5 million, up 18.58% year-over-year; the trailing twelve-month figure through Apr 2026 was -$8.5 million (up 18.58% YoY), and the FY2025 annual result was -$10.9 million, up 14.84% from the prior year.
• Enterprise Value came in at -$8.5 million for Q2 2026 at Pharma-Bio Serv, up from -$10.6 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$8.5 million in Q2 2026 to a low of -$15.9 million in Q1 2024.
• A 5-year average of -$13.0 million and a median of -$13.3 million in 2022 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value fell 3.56% in 2023 and advanced 22.75% in 2025, its largest moves.
• Over 5 years, Enterprise Value stood at -$14.5 million in 2022, then slipped by 3.56% to -$15.0 million in 2023, then gained by 14.9% to -$12.7 million in 2024, then increased by 14.84% to -$10.9 million in 2025, then gained by 21.95% to -$8.5 million in 2026.
• The last three Enterprise Value figures came in at -$8.5 million (Q2 2026), -$10.6 million (Q1 2026), and -$10.9 million (Q4 2025), per Business Quant data.